About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Nr4a3tm1Omc
targeted mutation 1, Orla M Conneely
MGI:3037444
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Nr4a3tm1Omc/Nr4a3tm1Omc involves: 129S/SvEv * C57BL/6 MGI:3037447
cx2
Nr4a1tm1Jmi/Nr4a1tm1Jmi
Nr4a3tm1Omc/Nr4a3tm1Omc
involves: 129S/SvEv * 129S2/SvPas * C57BL/6 MGI:3713721


Genotype
MGI:3037447
hm1
Allelic
Composition
Nr4a3tm1Omc/Nr4a3tm1Omc
Genetic
Background
involves: 129S/SvEv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr4a3tm1Omc mutation (1 available); any Nr4a3 mutation (54 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• adult homozygotes exhibited an increased susceptibility to kainic acid-induced limbic seizures by reaching stage 6 tonic-clonic convulsion faster than wild-type mice, and developed several seizures during the 45-min observation period while most wild-type mice developed only one stage 6 tonic-clonic convulsion
• at a high dosage of KA (25 mg/kg), 4 out of 7 homozygotes died after continuous tonic-clonic convulsions compared with only 1 of 8 wild-type mice
• at a lower dosage of KA (15 mg/kg), 6 of 8 homozygotes and only 2 of 9 wild-type mice developed seizures
• homozygotes were viable and overtly normal; however, 6 of 18 mice failed a contact-righting test, but behaved similar to controls in an elevated-platform, reaching response and swimming tests
• by 3 weeks of age, abnormal hyperactive behavior was seen in 15% of mice
• by 3 weeks of age, partial bidirectional circling behavior was seen in 15% of mice
• circling behavior was interspersed with noncircling periods of feeding, grooming, and sleep
• a small % of adult homozygotes displayed brief freezing spells with tonic posturing that were exacerbated with handling

hearing/vestibular/ear
• reduced diameter of semicircular canals apparent by E16.5, also noted at P1
• diminished endolymphatic space
• roof of ampullas appear flattened at E16.5 and at P1
• abnormal vestibular function due to defective outgrowth of the semicircular canals of the inner ear

nervous system
• adult homozygotes exhibited an increased susceptibility to kainic acid-induced limbic seizures by reaching stage 6 tonic-clonic convulsion faster than wild-type mice, and developed several seizures during the 45-min observation period while most wild-type mice developed only one stage 6 tonic-clonic convulsion
• at a high dosage of KA (25 mg/kg), 4 out of 7 homozygotes died after continuous tonic-clonic convulsions compared with only 1 of 8 wild-type mice
• at a lower dosage of KA (15 mg/kg), 6 of 8 homozygotes and only 2 of 9 wild-type mice developed seizures
• a small % of adult homozygotes displayed brief freezing spells with tonic posturing that were exacerbated with handling
• small but significant increase of apoptosis in CA1 pyramidal neurons as early as P0, with maximal cell death noted at P5
• by P7, apoptosis in CA1 pyramidal cell layer was decreased to the level of wild-type mice
• no cellular loss due to apoptosis was observed in the CA3 region
• reduced outgrowth of granule cell mossy fibers into CA3 stratum lucidum, noted at P7, P14 and through adulthood
• reduced outgrowth of mossy cell axons into the suprapyramidal blade in the inner molecular layer of the dentate gyrus, noted at P14 and through adulthood
• abnormal postnatal axonal guidance of dentate gyrus granule and mossy cells
• abnormal early postnatal hippocampal development due to defective hippocampal axonal growth and postnatal neuronal cell death
• absence of a compact pyramidal cell layer of Ammon's horn, as shown at the levels of CA3 and CA1
• pyramidal cell layer disorganization both at the level of CA3 and CA1, evident at P7 and exacerbated at P14 and P21
• significant reduction in the total number of pyramidal cells in the CA1 region but not in the CA3 region of the hippocampus
• loss of pyramidal CA1 neurons during early postnatal stages of development, with maximal loss at P14 and P21 that persists to adulthood

cellular
• small but significant increase of apoptosis in CA1 pyramidal neurons as early as P0, with maximal cell death noted at P5
• by P7, apoptosis in CA1 pyramidal cell layer was decreased to the level of wild-type mice
• no cellular loss due to apoptosis was observed in the CA3 region
• reduced outgrowth of granule cell mossy fibers into CA3 stratum lucidum, noted at P7, P14 and through adulthood
• reduced outgrowth of mossy cell axons into the suprapyramidal blade in the inner molecular layer of the dentate gyrus, noted at P14 and through adulthood
• abnormal postnatal axonal guidance of dentate gyrus granule and mossy cells




Genotype
MGI:3713721
cx2
Allelic
Composition
Nr4a1tm1Jmi/Nr4a1tm1Jmi
Nr4a3tm1Omc/Nr4a3tm1Omc
Genetic
Background
involves: 129S/SvEv * 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr4a1tm1Jmi mutation (3 available); any Nr4a1 mutation (39 available)
Nr4a3tm1Omc mutation (1 available); any Nr4a3 mutation (54 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice fail to thrive and die between 2 - 4 weeks after birth

neoplasm
• acute myeloid leukemia that is rapidly lethal and transplantable
• perivascular infiltrates are seen in nonhematopoietic tissues including the liver and lung
• disseminated myeloid cells are seen in the spleen and lung

hematopoietic system
• severe disruption of the architecture at 2 - 3 weeks of age
• significant expansion of myeloid progenitors
• immature blasts make up as much as 80% of white blood cells
• increase in the number of CD11b+ progenitor cells and these cells display a significant increase in the number of cells in the S and G2/M phases of the cell cycle
• at 2 -3 weeks of age
• reduction in the number of lymphoid and erythroid cells and increase in the number of granulocytes
• marked reduction of the number of lymphoid cells in the spleen, bone marrow, and thymus
• variable incidence of leukocytosis at 2 -3 weeks of age
• however, all homozygotes show an increase in immature/blast myeloid forms in the bone marrow, spleen, and peripheral blood
• marked expansion of granulocytes in the bone marrow, spleen, thymus, and lymph nodes
• variable incidence of eosinophilia at 2 -3 weeks of age
• variable incidence of eosinophilia at 2 -3 weeks of age
• 2.6-fold increase in the number of long term hematopoietic stem cells in bone marrow
• however, the number of short term hematopoietic stem cells is not increased
• severe disruption of the architecture at 2 - 3 weeks of age
• at 2 -3 weeks of age

growth/size/body
• at 2 -3 weeks of age
• at 2 -3 weeks of age

behavior/neurological

liver/biliary system
• at 2 -3 weeks of age

immune system
• severe disruption of the architecture at 2 - 3 weeks of age
• immature blasts make up as much as 80% of white blood cells
• increase in the number of CD11b+ progenitor cells and these cells display a significant increase in the number of cells in the S and G2/M phases of the cell cycle
• marked reduction of the number of lymphoid cells in the spleen, bone marrow, and thymus
• variable incidence of leukocytosis at 2 -3 weeks of age
• however, all homozygotes show an increase in immature/blast myeloid forms in the bone marrow, spleen, and peripheral blood
• marked expansion of granulocytes in the bone marrow, spleen, thymus, and lymph nodes
• variable incidence of eosinophilia at 2 -3 weeks of age
• variable incidence of eosinophilia at 2 -3 weeks of age
• severe disruption of the architecture at 2 - 3 weeks of age
• at 2 -3 weeks of age
• at 2 -3 weeks of age

integument

endocrine/exocrine glands
• severe disruption of the architecture at 2 - 3 weeks of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
acute myeloid leukemia DOID:9119 OMIM:601626
J:121903





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/09/2024
MGI 6.24
The Jackson Laboratory